Emergence and properties of spice and bath salts: A medicinal chemistry perspective

Life Sciences

Volumn 97, Issue 1, 2014, Pages 9-19

  Lewin, Anita H ^a   Seltzman, Herbert H ^a   Carroll, F Ivy ^a   Mascarella, S Wayne ^a   Reddy, P Anantha ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

5HT; Cathinone; CB1; CB2; DAT; JWH; NET; Releaser; SERT; TAAR1

Indexed keywords

5HT; CATHINONE; CB1; CB2; DAT; JWH; NET; RELEASER; SERT; TAAR1;

ALKALOIDS; ANIMALS; CANNABINOIDS; CATHA; DESIGNER DRUGS; HUMANS; INTERNET; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 84894055173     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.09.026     Document Type: Review

References (94)

1. B.K. Atwood, D. Lee, A. Straiker, T.S. Widlanski, and K. Mackie CP47497-C8 and JWH073, commonly found in 'Spice' herbal blends, are potent and efficacious CB1 cannabinoid receptor agonists Eur J Pharmacol 659 2011 139 145
2. B.D. Berrang, A.H. Lewin, and F.I. Carroll Enantiomeric α-aminopropiophenones (cathinone): preparation and investigation J Org Chem 47 1982 2643 2647 (Pubitemid 12008344)
3. L.K. Brents, E.E. Reichard, S.M. Zimmerman, J.H. Moran, W.E. Fantegrossi, and P.L. Prather Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH 018 Retain in vitro and in vivo cannabinoid receptor affinity and activity PLoS One 6 2011 e21917
4. L.K. Brents, A. Gallus-Zawada, A. Radominska-Pandya, T. Vasiljevik, T.E. Prisinzano, and W.E. Fantegrossi et al. Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity Biochem Pharmacol 83 2012 952 961
5. K.N. Cameron, R. Kolanos, E. Solis Jr., R.A. Glennon, and L.J. De Felice Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter Br J Pharmacol 168 2013 1750 1757
6. F.I. Carroll, A.H. Lewin, S.W. Mascarella, H.H. Seltzman, and P.A. Reddy Designer drugs: a medicinal chemistry perspective Ann N Y Acad Sci 1248 2012 18 38
7. K.C. Chimalakonda, K.A. Seely, S.M. Bratton, L.K. Brents, C.L. Moran, and G.W. Endres et al. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands Drug Metab Dispos 40 2012 2174 2184
8. M. Coppola, and R. Mondola 3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online Toxicol Lett 208 2012 12 15
9. R.A. Couch, and H. Madhavaram Phenazepam and cannabinomimetics sold as herbal highs in New Zealand Drug Test Anal 4 2012 409 414
10. N. De Brabanter, S. Esposito, G. Lore, L. Lootens, P. Meuleman, and G. Leroux-Roels et al. In vitro and in vivo metabolisms of 1-pentyl-3-(4-methyl-1- naphthoyl)indole (JWH-122) Forensic Toxicol 2013 10.1007/s11419-013-0179-4
11. R. de la Torre, M. Farre, P.N. Roset, N. Pizarro, S. Abanades, and M. Segura et al. Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition Ther Drug Monit 26 2004 137 144 (Pubitemid 38501207)
12. A. Derungs, S. Schietzel, M.R. Meyer, H.H. Maurer, S. Krahenbuhl, and M.E. Liechti Sympathomemetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphtylpyrovalerone) Clin Toxicol 49 2011 691 693
13. A. Derungs, A.E. Schwaninger, G. Mansella, R. Bingisser, T. Kraemer, and M.E. Liechti Symptoms, toxicities, and analytical results for a patient after smoking herbs containing the novel synthetic cannabinoid MAM-2201 Forensic Toxicol 31 2013 164 171
14. T.S. Emerson, and J.E. Cisek Methcathinone: a Russian designer amphetamine infiltrates the rural midwest Ann Emerg Med 22 1993 1897 1903 (Pubitemid 23346166)
15. L. Ernst, H.-M. Schiebel, C. Theuring, R. Lindigkeit, and T. Beuerle Identification and characterization of JWH-122 used as new ingredient in "Spice-like" herbal incenses Forensic Sci Int 208 2011 e31 e35
16. L. Ernst, K. Krüger, R. Lindigkeit, H.-M. Schiebel, and T. Beuerle Synthetic cannabinoids in "spice-like" herbal blends: first appearance of JWH-307 and recurrence of JWH-018 on the German market Forensic Sci Int 222 2012 216 222
17. L. Fattore, and W. Fratta Beyond THC: the new generation of cannabinoid designer drugs Front Behav Neurosci 5 2011 60
18. J.M. Frost, M.J. Dart, K.R. Tietje, T.R. Garrison, G.K. Grayson, and A.V. Daza et al. Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity J Med Chem 53 2010 295 315
19. G.L. Gardner, K. Spiller, and Z.-X. Xi Cannabinoid Cb1 and Cb2 Receptors modulate brain reward function in opposite directions in rats 20th Annual Symposium of the International Cannabinoid Research Society. Lund, Sweden 2010 35
20. S. Gibbons, and M. Zloh An analysis of the 'legal high' mephedrone Bioorg Med Chem Lett 20 2010 4135 4139
21. R.A. Glennon, and R. Young Effect of 1-(3,4-methylenedioxyphenyl)-2- aminopropane and its optical isomers in PMMA-trained rats Pharmacol Biochem Behav 72 2002 307 311 (Pubitemid 34251340)
22. R.A. Glennon, M. Yousif, N. Naiman, and P. Kalix Methcathinone: a new and potent amphetamine-like agent Pharmacol Biochem Behav 26 1987 547 551 (Pubitemid 17047729)
23. R.A. Glennon, R. Young, M. Dukat, and Y. Cheng Initial characterization of PMMA as a discriminative stimulus Pharmacol Biochem Behav 57 1997 151 158 (Pubitemid 27261405)
24. B.A. Gosnell, J.M. Yracheta, S.M. Bell, and K.E. Lane Intravenous self-administration of cathinone by rats Behav Pharmacol 7 1996 526 531 (Pubitemid 27046782)
25. M. Grabenauer, W.L. Krol, J.L. Wiley, and B.F. Thomas Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: implications for nontargeted screening of designer drugs Anal Chem 84 2012 5574 5581
26. A. Gregori, F. Damiano, M. Bonavia, V. Mileo, F. Varani, and M. Monfreda Identification of two cannabimimetic compounds WIN48098 and AM679 in illegal products Sci Justice 53 2013 286 292
27. A. Grigoryev, P. Kavanagh, and A. Melnik The detection of the urinary metabolites of 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone (AM-694), a high affinity cannabimimetic, by gas chromatography - mass spectrometry Drug Test Anal 5 2013 110 115
28. J.W. Huffman, L.W. Padgett, M.L. Isherwood, J.L. Wiley, and B.R. Martin 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptors Bioorg Med Chem Lett 16 2006 5432 5435 (Pubitemid 44332197)
29. C.E. Johanson, and C.R. Schuster A comparison of the behavioral effects of l- and dl-cathinone and d-amphetamine J Pharmacol Exp Ther 219 1981 355 362 (Pubitemid 12252031)
30. L.D. Johnston, P.M. O'Malley, J.G. Bachman, and J.E. Schulenberg Monitoring the future national results on drug use: 2012 overview, key findings on adolescent drug use 2013 Institute for Social Research, The University of Michigan Ann Arbor
31. P. Kalix Pharmacological properties of the stimulant khat Pharmacol Ther 48 1990 397 416
32. H.T. Kamata, N. Shima, K. Zaitsu, T. Kamata, A. Miki, and M. Nishikawa et al. Metabolism of the recently encountered designer drug, methylone, in humans and rats Xenobiotica 36 2006 709 723 (Pubitemid 44195985)
33. L. Karila, and M. Reynaud GHB and synthetic cathinones: clinical effects and potential consequences Drug Test Anal 3 2011 552 559
34. P. Kavanagh, A. Grigoryev, S. Savchuk, I. Mikhura, and A. Formanovsky UR-144 in products sold via the Internet: identification of related compounds and characterization of pyrolysis products Drug Test Anal 5 2013 683 692
35. J.P. Kelly Cathinone derivatives: a review of their chemistry, pharmacology and toxicology Drug Test Anal 3 2011 439 453
36. R. Kikura-Hanajiri, N. Uchiyama, M. Kawamura, and Y. Goda Changes in the prevalence of synthetic cannabinoids and cathinone derivatives in Japan until early 2012 Forensic Toxicol 31 2013 44 53
37. S. Kneisel, and V. Auwarter Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction J Mass Spectrom 47 2012 825 835
38. S. Kneisel, P. Bisel, V. Brecht, S. Broecker, M. Müller, and V. Auwärter Identification of the cannabimimetic AM-1220 and its azepane isomer (N-methylazepan-3-yl)-3-(1-naphthoyl)indole in a research chemical and several herbal mixtures Forensic Toxicol 30 2012 126 134
39. S. Kneisel, F. Westphal, P. Bisel, V. Brecht, S. Broecker, and V. Auwarter Identification and structural characterization of the synthetic cannabinoid 3-(1-adamantoyl)-1-pentylindole as an additive in 'herbal incense' J Mass Spectrom 47 2012 195 200
40. League of nations report by advisory committee on the traffic in opium and other dangerous drugs eleventh S 1935 16 [17, 24]
41. Lewin AH. unpublished.
42. A.H. Lewin, G.M. Miller, and B.P. Gilmour Trace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine class Bioorg Med Chem 19 2011 7044 7048
43. P.J. Little, D.R. Compton, M.R. Johnson, L.S. Melvin, and B.R. Martin Pharmacology and stereoselectivity of structurally novel cannabinoids in mice J Pharmacol Exp Ther 247 1988 1046 1051 (Pubitemid 19022114)
44. B.K. Madras, P.C. Meltzer, and D. Butler Pyrovalerone analogs and therapeutic uses thereof. EP 1,670,755 2006
45. Y. Makino, T. Higuchi, S. Ohta, and M. Hirobe Identification and quantification of p-hydroxyethylamphetamine as a novel metabolite of ethylamphetamine in rat by gas chromatography-mass specrometry Forensic Sci Int 41 1989 83 91 (Pubitemid 19144655)
46. P.C. Meltzer, D. Butler, J.R. Deschamps, and B.K. Madras 1-(4-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: a promising class of monoamine uptake inhibitors J Med Chem 49 2006 1420 1432 (Pubitemid 43271895)
47. B. Moosmann, S. Kneisel, U. Girreser, V. Brecht, F. Westphal, and V. Auwärter Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen- 1-yl)methanone using GC-MS, NMR analysis and a flash chromatography system Forensic Sci Int 220 2012 e17 e22
48. J. Nakajima, M. Takahashi, R. Nonaka, T. Seto, J. Suzuki, and M. Yoshida et al. Identification and quantitation of a benzoylindole (2-methoxyphenyl)(1- pentyl-1H-indol-3-yl)methanone and a naphthoylindole 1-(5-fluoropentyl-1H-indol- 3-yl) (naphthalene-1-yl)methanone (AM-2201) found in illegal products obtained via the Internet and their cannabimimetic effects evaluated by in vitro [35S]GTPγS binding assays Forensic Toxicol 29 2011 132 141
49. J. Nakajima, M. Takahashi, T. Seto, and J. Suzuki Identification and quantitation of cannabimimetic compound JWH-250 as an adulterant in products obtained via the Internet Forensic Toxicol 29 2011 51 55
50. J.-I. Nakajima, M. Takahashi, T. Seto, C. Kanai, J. Suzuki, and M. Yoshida et al. Identification and quantitation of two benzoylindoles AM-694 and (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone, and three cannabimimetic naphthoylindoles JWH-210, JWH-122, and JWH-019 as adulterants in illegal products obtained via the Internet Forensic Toxicol 29 2011 95 110
51. J. Nakajima, M. Takahashi, T. Seto, M. Yoshida, C. Kanai, and J. Suzuki et al. Identification and quantitation of two new naphthoylindole drugs-of-abuse, (1-(5-hydroxypentyl)-1H-indol-3-yl) (naphthalen-1-yl)methanone (AM-2202) and (1-(4-pentenyl)- 1H-indol-3-yl (naphthalen-1-yl)methanone, with other synthetic cannabinoids in unregulated "herbal" products circulated in the Tokyo ar Forensic Toxicol 30 2012 33 44
52. J. Nakajima, M. Takahashi, T. Seto, C. Kanai, J. Suzuki, and M. Yoshida et al. Analysis of azepane isomers of AM-2233 and AM-1220, and detection of an inhibitor of fatty acid amide hydrolase [30-(aminocarbonyl)(1,10-biphenyl)-3-yl] -cyclohexylcarbamate (URB597) obtained as designer drugs in the Tokyo area Forensic Toxicol 31 2013 76 85
53. D. Nutt Drugs without the hot air 2012 UIT Cambridge Ltd. Cambridge, England 72 90
54. ONDCP Synthetic drugs (a.k.a. K2, Spice, bath salts, etc.). Office of National Drug Control Policy Fact Sheet: synthetic drugs 2012 [February:1]
55. Y. Park, C. Lee, H. Lee, J. Pyo, J. Jo, and J. Lee et al. Identification of a new synthetic cannabinoid in a herbal mixture: 1-butyl-3-(2-methoxybenzoyl) indole Forensic Toxicol 31 2013 187 196
56. J.L. Poklis, D. Amira, L.E. Wise, J.M. Wiebelhaus, B.J. Haggerty, and A. Poklis Detection and disposition of JWH-018 and JWH-073 in mice after exposure to "Magic Gold" smoke Forensic Sci Int 220 2012 91 96
57. J.M. Prosser, and L.S. Nelson The toxicology of bath salts: a review of synthetic cathinones J Med Toxicol 8 2012 33 42
58. M. Rajasekaran, L.K. Brents, L.N. Franks, J.H. Moran, and P.L. Prather Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors Toxicol Appl Pharmacol 269 2013 100 108
59. J.B. Rangisetty, M.L. Bondarev, J. Chang-Fong, R. Young, and R.A. Glennon PMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA Pharmacol Biochem Behav 69 2001 261 267 (Pubitemid 32566271)
60. R.B. Rothman, N. Vu, J.S. Partilla, B.L. Roth, S.J. Hufeisen, and B.A. Compton-Toth et al. In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates J Pharmacol Exp Ther 307 2003 138 145 (Pubitemid 37151899)
61. C. Sauer, F.T. Peters, C. Haas, M.R. Meyer, G. Fritschi, and H.H. Maurer New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques J Mass Spectrom 44 2009 952 964
62. C. Sauer, K. Hoffmann, U. Schimmel, and F.T. Peters Acute poisoning involving the pyrrolidinophenone-type designer drug 4′-methyl-alpha- pyrrolidinohexanophenone (MPHP) Forensic Sci Int 208 2011 e20 e25
63. M.D. Schwartz Acute kidney injury associated with synthetic cannabinoid use - multiple states, 2012 MMWR Morb Mortal Wkly Rep 62 2013 93 98
64. K.A. Seely, J. Lapoint, J.H. Moran, and L. Fattore Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids Prog Neuropsychopharmacol Biol Psychiatry 39 2012 234 243
65. K.G. Shanks, T. Dahn, G. Behonick, and A. Terrell Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry J Anal Toxicol 36 2012 360 371
66. V. Shevyrin, V. Melkozerov, A. Nevero, O. Eltsov, Y. Morzherin, and Y. Shafran Identification and analytical properties of new synthetic cannabimimetics bearing 2,2,3,3-tetramethylcyclopropanecarbonyl moiety Forensic Sci Int 226 2013 62 73
67. L.D. Simmler, T.A. Buser, M. Donzelli, Y. Schramm, L.-H. Dieu, and J. Huwyler et al. Pharmacological characterization of designer cathinones in vitro Brit J Pharmacol 168 2013 458 470
68. D. Springer, G. Fritschi, and H.H. Maurer Metabolism and toxicological detection of the new designer drug 3′,4′-methylenedioxy-alpha- pyrrolidinopropiophenone studied in urine using gas chromatography-mass spectrometry J Chromatogr B 793 2003 377 388 (Pubitemid 37271978)
69. D. Springer, G. Fritschi, and H.H. Maurer Metabolism and toxicological detection of the new designer drug 4′-methoxy-alpha- pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry J Chromatogr B 793 2003 331 342 (Pubitemid 37271973)
70. D. Springer, G. Fritschi, and H.H. Maurer Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4′-methyll-alpha-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry J Chromatogr B 796 2003 253 266 (Pubitemid 37329670)
71. R.F. Staack, and H.H. Maurer Metabolism of designer drugs of abuse Curr Drug Metab 6 2005 259 274 (Pubitemid 40753856)
72. K. Takahashi, N. Uchiyama, T. Fukiwake, T. Hasegawa, M. Saijou, and Y. Motoki et al. Identification and quantitation of JWH-213, a cannabimimetic indole, as a designer drug in a herbal product Forensic Toxicol 31 2013 145 150
73. N. Uchiyama, R. Kikura-Hanajiri, N. Kawahara, Y. Haishima, and Y. Goda Identification of a cannabinoid analog as a new type of designer drug in a herbal product Chem Pharm Bull 57 2009 439 441
74. N. Uchiyama, M. Kawamura, R. Kikura-Hanajiri, and Y. Goda Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products Forensic Toxicol 29 2011 25 37
75. N. Uchiyama, R. Kikura-Hanajiri, and Y. Goda Identification of a novel cannabimimetic phenylacetylindole, cannabipiperidiethanone, as a designer drug in a herbal product and its affinity for cannabinoid CB1 and CB2 receptors Chem Pharm Bull 59 2011 1203 1205
76. N. Uchiyama, R. Kikura-Hanajiri, T. Shoda, K. Fukuhara, and Y. Goda Isomeric analysis of synthetic cannabinoids detected as designer drugs Yakugaku Zasshi 131 2011 1141 1147
77. N. Uchiyama, M. Kawamura, R. Kikura-Hanajiri, and Y. Goda Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3- carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products Forensic Toxicol 30 2012 114 125
78. N. Uchiyama, M. Kawamura, R. Kikura-Hanajiri, and Y. Goda URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products Forensic Sci Int 227 2013 21 32
79. N. Uchiyama, S. Matsuda, M. Kawamura, R. Kikura-Hanajiri, and Y. Goda Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative a-PVT and an opioid receptor agonist AH-7921 identified in illegal products Forensic Toxicol 31 2013 223 240
80. N. Uchiyama, S. Matsuda, D. Wakana, R. Kikura-Hanajiri, and Y. Goda New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-xobutan-2-yl)-1- pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan- 2-yl)-1- (4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products Forensic Toxicol 31 2013 93 100
81. USNavyMedicine Bath salts: it's not a fad. it's a nightmare 2012 http://www.youtube.com/watch?v=mhlaHwnErBI
82. E. Valoti, E. Casagni, L. Dell'Acqua, M. Pallavicini, G. Roda, and C. Rusconi et al. Identification of 1-butyl-3-(1-(4-methyl)naphtoyl)indole detected for the first time in "herbal high" products on the Italian market Forensic Sci Int 223 2012 e42 e46
83. P. Widler, K. Mathys, R. Brenneisen, P. Kalix, and H.U. Fisch Pharmacodynamics and pharmacokinetics of khat: a controlled study Clin Pharmacol Ther 55 1994 556 562 (Pubitemid 24192241)
84. J.M. Wiebelhaus, J.L. Poklis, A. Poklis, R.E. Vann, A.H. Lichtman, and L.E. Wise Inhalation exposure to smoke from synthetic "marijuana" produces potent cannabimimetic effects in mice Drug Alcohol Depend 126 2012 316 323
85. J.L. Wiley, J.A. Marusich, B.R. Martin, and J.W. Huffman 1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice Drug Alcohol Depend 123 2012 148 153
86. A.R. Winstock, and M.J. Barratt Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample Drug Alcohol Depend 131 2013 106 111
87. E.H. Woodruff, J.P. Lambooy, and W.E. Burt Physiologically active amines. III. Secondary and teriary beta-phenylpropylamines and beta- phenylisopropylamines J Am Chem Soc 40 1940 922 924
88. W.L. Woolverton, and C.E. Johanson Preference in rhesus monkeys given a choice between cocaine and d, l-cathinone J Exp Anal Behav 41 1984 35 43
89. Z. Xie, and G.M. Miller A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain J Pharmacol Exp Ther 330 2009 316 325
90. R. Young, and R.A. Glennon Discriminative stimulus effects of S(-)-methcathinone (CAT): a potent stimulant drug of abuse Psychopharmacology (Berl) 140 1998 250 256 (Pubitemid 28562444)
91. R. Young, and R.A. Glennon MDMA (N-methyl-3,4-methylenedioxyamphetamine) and its stereoisomers: similarities and differences in behavioral effects in an automated activity apparatus in mice Pharmacol Biochem Behav 88 2008 318 331 (Pubitemid 350116259)
92. A.C. Young, E. Schwarz, G. Medina, A. Obafemi, S.-Y. Feng, and C. Kane et al. Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation Am J Emerg Med 30 2012 1320.e5 1320.e7
93. H. Yu, R.B. Rothman, C.M. Dersch, J.S. Partilla, and K.C. Rice Uptake and release of diethylpropion and its metabolites with biogenic amine transporters Bioorg Med Chem 8 2000 2689 2692
94. K.Y. Zhingel, W. Dovensky, A. Crossman, and A. Allen Ephedrone: 2-methylamino-1-phenlypropan-1-one (Jeff) J Forensic Sci 36 1991 915 920